Related Experiment Video
Updated: Jun 12, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Antiviral treatment of chikungunya virus infection
Xavier de Lamballerie1, Laetitia Ninove, Rémi N Charrel
1Unité des Virus Emergents, UMR190 IRD / Université de la Méditerranée / Assistance Publique-Hôpitaux de Marseille, Faculté de Médecine, Marseille, France. Xavier.de-lamballerie@univmed.fr
Abstract:
Chikungunya virus is a typical emerging virus which has been responsible for several million cases of human infections since 2004. No antiviral treatment is currently available. The antimalarial chloroquine has been used in the past but recent studies suggest that it is not or poorly active in vivo. A number of tracks are currently under investigation (inhibition of viral enzymes, of virus entry or maturation, enhancement of immunological response) and new animal models have been made available, including a mouse model and a non-human primate model. We review here the main perspectives of chikungunya antiviral treatment.
Related Concept Videos
Retrovirus Life Cycles
Myocarditis III: Medical Management
Yellow Fever
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors

